Chronic conditions | Â | NSAID use % (n = 357) | Â | NSAID use (n = 176) | Â | Cox-2 inhibitor use (n = 187) | Â |
---|---|---|---|---|---|---|---|
Joint pain | No | 2.2 (23) | < 0.01 | 1.6 (17) | < 0.01 | 0.7 (7) | < 0.01 |
 | Yes |  |  |  |  |  |  |
 | Diagnosed as arthritis | 27.6 (247) |  | 11.2 (100) |  | 16.9 (151) |  |
 | Not diagnosed as arthritis | 6.7 (79) |  | 4.9 (57) |  | 2.0 (23) |  |
Cardiovascular disease/stroke | No | 10.2 (289) | < 0.01 | 5.3 (150) | 0.05 | 5.1 (144) | < 0.01 |
 | Yes | 20.0 (60) |  | 8.0 (24) |  | 12.0 (36) |  |
MI/angina | No | 10.6 (308) | < 0.01 | 5.4 (158) | 0.28 | 5.3 (155) | < 0.01 |
 | Yes | 18.8 (42) |  | 7.1 (16) |  | 11.6 (26) |  |
> 15% 10 year CVD risk | No | 10.4 (214) | 0.01 | 5.6 (115) | 0.44 | 5.0 (103) | < 0.01 |
 | Yes | 14.7 (56) |  | 6.6 (25) |  | 8.4 (32) |  |
Hypertension* | No | 7.7 (140) | < 0.01 | 4.6 (83) | < 0.01 | 3.2 (59) | < 0.01 |
 | Yes | 16.0 (217) |  | 6.9 (93) |  | 9.5 (128) |  |
Kidney disease** | No | 9.9 (245) | < 0.01 | 5.4 (134) | 0.58 | 4.7 (116) | < 0.01 |
 | Yes | 15.9 (109) |  | 6.0 (41) |  | 10.1 (69) |  |
Primary care provider visits in previous year | None | 3.5 (8) | < 0.01 | 3.1 (7) | < 0.01 | 0.4 (1) | < 0.01 |
 | 1-4 | 6.5 (103) |  | 3.6 (56) |  | 3.0 (47) |  |
 | ≥ 5 | 18.0 (239) |  | 8.4 (111) |  | 10.0 (133) |  |
Medication use | Â | Â | Â | Â | Â | Â | Â |
Anti-hypertensives | No | 9.3 (211) | < 0.01 | 5.1 (117) | 0.11 | 4.3 (98) | < 0.01 |
 | Yes | 16.3 (146) |  | 6.6 (59) |  | 9.9 (89) |  |
Diuretics | No | 10.7 (325) | < 0.01 | 5.5 (166) | 0.31 | 5.4 (164) | < 0.01 |
 | Yes | 24.1 (32) |  | 7.5 (10) |  | 17.3 (23) |  |
ACE inhibitors | No | 11.2 (314) | 0.69 | 5.3 (150) | 0.15 | 6.0 (169) | 0.43 |
 | Yes | 11.9 (43) |  | 7.2 (26) |  | 5.0 (18) |  |
Gastro-esophageal reflux | No | 9.0 (243) | < 0.01 | 4.9 (134) | < 0.01 | 4.1 (112) | < 0.01 |
 | Yes | 24.7 (114) |  | 9.1 (42) |  | 16.3 (75) |  |